Clinical Trial Update: An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects [Phase 1]

View source ↗

Summary

This Phase 1 open-label study evaluated two formulations of LX1033 in healthy subjects to assess safety and tolerability. The study also collected preliminary p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• LX1033

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Irritable Bowel Syndrome | Phase 1 | Status: COMPLETED